Hajri A, Metzger E, Vallat F, Coffy S, Flatter E, Evrard S, Marescaux J, Aprahamian M
Institut de Recherche contre les Cancers de l'Appareil Digestif, Hôpitaux Universitaires, Strasbourg, France.
Br J Cancer. 1998 Oct;78(7):841-9. doi: 10.1038/bjc.1998.591.
Nitric oxide (NO), an endogenous free radical, has been implicated in a wide range of biological functions. NO is generated enzymatically from the terminal guanidinonitrogen of L-arginine by nitric oxide synthase (NOS). Despite intensive investigations, the role of NO--either as the primary product of the L-arginine/NOS pathway or provided from the NO donor sodium nitroprusside (SNP)--in carcinogenesis and tumour cell growth remains unclear and controversial. The objective of this study was to examine the growth effects of NO on a ductal pancreatic adenocarcinoma in the rat and on a human pancreatic tumour cell line (HA-hpc2). In vivo, both SNP and endogenous induction of NO by endotoxins [lipopolysaccharide (LPS)] plus L-arginine significantly reduced the tumour growth. To investigate the mechanisms of NO anti-tumour growth action, the effects of either the SNP or L-arginine/NOS pathway were analysed on the HA-hpc2 cell line. Nitrite/nitrate production, NOS activity and iNOS expression [assessed by reverse transcription-polymerase chain reaction (RT-PCR)] were tested and related to growth (assessed by [3H]thymidine incorporation assay) and apoptosis (assessed by internucleosomal DNA cleavage). SNP exerted a dual effect on tumour cells: stimulation of the proliferation up to 1 mM and inhibition at higher concentrations. These effects were related to NO production. Both proliferative and cytostatic responses were inhibited by NO scavenger 2-phenyl-4,4,5,5-tetramethyl-hemidazoline-1-oxyl3-oxide (carboxy-PTIO). The marked apoptotic DNA fragmentation induced by SNP was also abolished by PTIO association. Unlike macrophages, the human pancreatic tumour cells did not seem to express intrinsically the L-arginine/NOS pathway. Macrophages were activated by HA-hpc2 cells as well as by LPS plus cytokines [interleukin (IL)-1beta plus tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma]. In HA-hpc2/macrophage co-cultures, NOS activity and inducible NOS (iNOS) transcription were stimulated, whereas an antiproliferative response was observed. These effects were related to both macrophage amount and NO production. Addition of LPS plus cytokines to co-cultures doubled iNOS activity, nitrite/nitrate production and tumoricidal effect. These data suggest the involvement of NO in pancreatic tumour growth and support the fact that generation of high levels of NO with potential production of endogenous reactive nitrogen intermediates may contribute to induction of apoptosis and tumour growth inhibition.
一氧化氮(NO)是一种内源性自由基,参与多种生物学功能。NO由一氧化氮合酶(NOS)催化L-精氨酸的末端胍基氮生成。尽管进行了深入研究,但NO作为L-精氨酸/NOS途径的主要产物或由NO供体硝普钠(SNP)提供,在致癌作用和肿瘤细胞生长中的作用仍不明确且存在争议。本研究的目的是研究NO对大鼠胰腺导管腺癌和人胰腺肿瘤细胞系(HA-hpc2)生长的影响。在体内,SNP以及内毒素[脂多糖(LPS)]加L-精氨酸诱导的内源性NO均显著降低肿瘤生长。为了研究NO抗肿瘤生长作用的机制,分析了SNP或L-精氨酸/NOS途径对HA-hpc2细胞系的影响。检测了亚硝酸盐/硝酸盐生成、NOS活性和诱导型NOS(iNOS)表达[通过逆转录-聚合酶链反应(RT-PCR)评估],并与生长[通过[3H]胸苷掺入试验评估]和凋亡[通过核小体间DNA裂解评估]相关。SNP对肿瘤细胞有双重作用:在浓度高达1 mM时刺激增殖,在更高浓度时抑制增殖。这些作用与NO生成有关。增殖和细胞抑制反应均被NO清除剂2-苯基-4,4,5,5-四甲基-咪唑啉-1-氧基3-氧化物(羧基-PTIO)抑制。PTIO联合使用也消除了SNP诱导的明显凋亡性DNA片段化。与巨噬细胞不同,人胰腺肿瘤细胞似乎不固有表达L-精氨酸/NOS途径。HA-hpc2细胞以及LPS加细胞因子[白细胞介素(IL)-1β加肿瘤坏死因子(TNF)-α和干扰素(IFN)-γ]激活巨噬细胞。在HA-hpc2/巨噬细胞共培养物中,NOS活性和诱导型NOS(iNOS)转录受到刺激,同时观察到抗增殖反应。这些作用与巨噬细胞数量和NO生成均有关。向共培养物中添加LPS加细胞因子使iNOS活性、亚硝酸盐/硝酸盐生成和杀肿瘤作用增加一倍。这些数据表明NO参与胰腺肿瘤生长,并支持以下事实:产生高水平NO以及潜在生成内源性活性氮中间体可能有助于诱导凋亡和抑制肿瘤生长。